Anti-interleukin-6 (tocilizumab) therapy in Takayasu’s arteritis: a real life experience

BACKGROUND/AIM: Tumour necrosis factor inhibitors and anti-interleukin-6 (anti-IL-6) therapies are increasingly being used in Takayasu’s arteritis (TA) patients who are unresponsive to corticosteroids ± conventional immunosuppressive agents. The aim of this study is to assess the efficacy and safety...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Turk J Med Sci
Main Authors: KILIÇ, Levent, KARADAĞ, Ömer, ERDEN, Abdulsamet, SARI, Alper, ARMAĞAN, Berkan, YARDIMCI, Gözde Kübra, FIRAT, Esra, KALYONCU, Umut, APRAŞ BİLGEN, Şule, KİRAZ, Sedat, ERTENLİ, İhsan, AKDOĞAN, Ali
Format: Artigo
Jezik:Inglês
Izdano: The Scientific and Technological Research Council of Turkey 2020
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7080363/
https://ncbi.nlm.nih.gov/pubmed/31655524
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3906/sag-1906-39
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki